Larimar Therapeutics
LRMR
58 hedge funds and large institutions have $485M invested in Larimar Therapeutics in 2014 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 20 increasing their positions, 9 reducing their positions, and 6 closing their positions.
233% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 6
122% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 9
68% more capital invested
Capital invested by funds: $289M → $485M (+$196M)
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
32% more funds holding
Funds holding: 44 → 58 (+14)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$6.19M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.9M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$2.32M |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
+$2.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.75M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$4.64M |
| 2 |
Jennison Associates
New York
|
-$2.41M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$1.67M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$1.47M |
| 5 |
Morgan Stanley
New York
|
-$1.32M |
LRMR Hedge Fund Activity: Q4 2014 in Review
58 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Larimar Therapeutics (LRMR) for Q4 2014, worth a combined $485M — up 68% from $289M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new LRMR positions and 6 closed out — a net gain of 14 holders — while 20 added to existing stakes and 9 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $6.19M. The largest seller was Sabby Management, cutting an estimated $4.64M.
- 58 institutional investors held Larimar Therapeutics (LRMR) as of Q4 2014, up from 44 in Q3 2014.
- Funds reported $485M of Larimar Therapeutics stock for Q4 2014, up 68% quarter-over-quarter.
- 20 funds opened new Larimar Therapeutics positions in Q4 2014 and 6 closed out, a net change of +14 holders.
- The largest Larimar Therapeutics buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $6.19M added.
- The largest Larimar Therapeutics seller in Q4 2014 was Sabby Management, an estimated $4.64M sold.
Based on aggregated 13F filings for Q4 2014.